CA2080759A1 - Aminoalkylamides - Google Patents

Aminoalkylamides

Info

Publication number
CA2080759A1
CA2080759A1 CA002080759A CA2080759A CA2080759A1 CA 2080759 A1 CA2080759 A1 CA 2080759A1 CA 002080759 A CA002080759 A CA 002080759A CA 2080759 A CA2080759 A CA 2080759A CA 2080759 A1 CA2080759 A1 CA 2080759A1
Authority
CA
Canada
Prior art keywords
compound
milligrams
acid
formula
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002080759A
Other languages
English (en)
French (fr)
Inventor
Robert A. Zambias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2080759A1 publication Critical patent/CA2080759A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002080759A 1991-10-17 1992-10-16 Aminoalkylamides Abandoned CA2080759A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/775,774 US5430018A (en) 1991-10-17 1991-10-17 Cyclohexapeptide with basic nitrogen containing alkylamide groups
US775,774 1991-10-17

Publications (1)

Publication Number Publication Date
CA2080759A1 true CA2080759A1 (en) 1993-04-18

Family

ID=25105458

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002080759A Abandoned CA2080759A1 (en) 1991-10-17 1992-10-16 Aminoalkylamides

Country Status (4)

Country Link
US (1) US5430018A (enExample)
EP (1) EP0538027A2 (enExample)
JP (1) JPH0794471B2 (enExample)
CA (1) CA2080759A1 (enExample)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product
US4931352A (en) * 1987-10-07 1990-06-05 Merck & Co., Inc. Antifungal fermentation product
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
MY136593A (en) * 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof

Also Published As

Publication number Publication date
JPH0794471B2 (ja) 1995-10-11
EP0538027A3 (enExample) 1994-04-06
JPH05239097A (ja) 1993-09-17
US5430018A (en) 1995-07-04
EP0538027A2 (en) 1993-04-21

Similar Documents

Publication Publication Date Title
US6030944A (en) Cyclohexapeptidyl bisamine compounds
US5330973A (en) Lipopeptide derivatives
AU677656B2 (en) Cyclohexapeptidyl amine compounds
EP0805685B1 (en) Novel antifungal cyclohexapeptides
US5741775A (en) Cyclohexapeptidyl aminoalkyl ethers
US5516756A (en) Aza cyclohexapeptide compounds
CA2079171C (en) Cyclohexapeptidyl propanolamine compounds
EP0781141B1 (en) Aza cyclohexapeptide compounds
US5914313A (en) 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5399552A (en) Antibiotic peptides bearing aminoalkylthioether moieties
WO1994025050A1 (en) Cyclohexapeptidyl propanolamine compounds
US5430018A (en) Cyclohexapeptide with basic nitrogen containing alkylamide groups
US5874403A (en) Amino acid conjugates of cyclohexapeptidyl amines
US5348940A (en) Cyclohexapeptidyl hydroxypropionitrile compounds
US5385884A (en) Lipopeptide derivatives
US5854212A (en) Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
AU707664B2 (en) Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
GB2271571A (en) Aminoalkyl ether of cyclohexapeptidylamine compounds
CA2197209C (en) Aza cyclohexapeptide compounds

Legal Events

Date Code Title Description
FZDE Discontinued